Review



polyclonal ab against intermediate peptide  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology polyclonal ab against intermediate peptide
    FIG. 2. Both RNA transcripts and proteins of DFF35/45 exist in vivo. A, DFF35 and DFF45 were amplified by human DFF35 (lanes 1 and 3) and DFF45 (lanes 2 and 4) out-encoding region primer sets in human fetal liver cDNA (lanes 1 and 2) or Jurkat cell line (lanes 3 and 4) using PCR. B, expression of DFF45 and DFF35 in Jurkat cells was immunoblotted by <t>polyclonal</t> Ab specific for N-terminal (lane 1), inter- mediate (lane 2), or C-terminal (lane 3), respectively. C, lysate of 293T cells transfected with DFF45 (lane1), DFF35 (lane 2), or an irrelevant protein p53 (lane 3) was immunoblotted by anti-Flag (M5) Ab (top panel), or anti DFF45/35 (bottom panel). Arrows indicate the trans- fected and endogenous DFF45 and DFF35.
    Polyclonal Ab Against Intermediate Peptide, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 94 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+ab+against+intermediate+peptide/Intermediate/pm10409614-59-1-25
    Average 93 stars, based on 94 article reviews
    polyclonal ab against intermediate peptide - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40."

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.

    Journal: The Journal of biological chemistry

    doi: 10.1074/jbc.274.30.20759

    FIG. 2. Both RNA transcripts and proteins of DFF35/45 exist in vivo. A, DFF35 and DFF45 were amplified by human DFF35 (lanes 1 and 3) and DFF45 (lanes 2 and 4) out-encoding region primer sets in human fetal liver cDNA (lanes 1 and 2) or Jurkat cell line (lanes 3 and 4) using PCR. B, expression of DFF45 and DFF35 in Jurkat cells was immunoblotted by polyclonal Ab specific for N-terminal (lane 1), inter- mediate (lane 2), or C-terminal (lane 3), respectively. C, lysate of 293T cells transfected with DFF45 (lane1), DFF35 (lane 2), or an irrelevant protein p53 (lane 3) was immunoblotted by anti-Flag (M5) Ab (top panel), or anti DFF45/35 (bottom panel). Arrows indicate the trans- fected and endogenous DFF45 and DFF35.
    Figure Legend Snippet: FIG. 2. Both RNA transcripts and proteins of DFF35/45 exist in vivo. A, DFF35 and DFF45 were amplified by human DFF35 (lanes 1 and 3) and DFF45 (lanes 2 and 4) out-encoding region primer sets in human fetal liver cDNA (lanes 1 and 2) or Jurkat cell line (lanes 3 and 4) using PCR. B, expression of DFF45 and DFF35 in Jurkat cells was immunoblotted by polyclonal Ab specific for N-terminal (lane 1), inter- mediate (lane 2), or C-terminal (lane 3), respectively. C, lysate of 293T cells transfected with DFF45 (lane1), DFF35 (lane 2), or an irrelevant protein p53 (lane 3) was immunoblotted by anti-Flag (M5) Ab (top panel), or anti DFF45/35 (bottom panel). Arrows indicate the trans- fected and endogenous DFF45 and DFF35.

    Techniques Used: In Vivo, Amplification, Expressing, Transfection

    FIG. 1. Comparison of amino acid sequences between DFF35 and DFF45 (A) or mouse ICAD-S (B). Two putative cleavage sites for caspase-3 are indicated by double underlines. Three peptides (N, I, and C) used to generate polyclonal antibodies are indicated by single under- lines. Identical amino acids between DFF35 and mouse ICAD-S are in bold face.
    Figure Legend Snippet: FIG. 1. Comparison of amino acid sequences between DFF35 and DFF45 (A) or mouse ICAD-S (B). Two putative cleavage sites for caspase-3 are indicated by double underlines. Three peptides (N, I, and C) used to generate polyclonal antibodies are indicated by single under- lines. Identical amino acids between DFF35 and mouse ICAD-S are in bold face.

    Techniques Used: Comparison

    FIG. 3. Inhibitory effect of DFF35 in vitro and in vivo. A, Jurkat cells were treated with 1 mg/ml Fas monoclonal Ab 7C11 for 2 h, and 100 ng of cytosolic fraction without (lane 1) or with GST (lanes 2 and 3), GST-DFF35 (lanes 4 and 5), or double mutated GST-DFF35 (lanes 6 and 7) was added to Jurkat nuclei and incubated at 37 °C for 2 h in the presence (lanes 3, 5, and 7) or absence (lanes 1, 2, 4, and 6) of caspase-3, respectively. Jurkat cells were treated with 1 mg/ml of staurosporine for the indicated time, cell lysates were blotted with polyclonal Ab reactive to N-terminal peptide of DFF45 and DFF35 (B), and genomic DNA were extracted and subjected to analysis by 2% agarose gel electrophoresis (C).
    Figure Legend Snippet: FIG. 3. Inhibitory effect of DFF35 in vitro and in vivo. A, Jurkat cells were treated with 1 mg/ml Fas monoclonal Ab 7C11 for 2 h, and 100 ng of cytosolic fraction without (lane 1) or with GST (lanes 2 and 3), GST-DFF35 (lanes 4 and 5), or double mutated GST-DFF35 (lanes 6 and 7) was added to Jurkat nuclei and incubated at 37 °C for 2 h in the presence (lanes 3, 5, and 7) or absence (lanes 1, 2, 4, and 6) of caspase-3, respectively. Jurkat cells were treated with 1 mg/ml of staurosporine for the indicated time, cell lysates were blotted with polyclonal Ab reactive to N-terminal peptide of DFF45 and DFF35 (B), and genomic DNA were extracted and subjected to analysis by 2% agarose gel electrophoresis (C).

    Techniques Used: In Vitro, In Vivo, Incubation, Agarose Gel Electrophoresis

    Related Articles

    In Vivo:

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
    Article Snippet: Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.. A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.. A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.

    Amplification:

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
    Article Snippet: Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.. A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.. A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.

    Expressing:

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
    Article Snippet: Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.. A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.. A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.

    Transfection:

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
    Article Snippet: Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.. A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.. A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.

    Comparison:

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
    Article Snippet: Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.. A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.. A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.

    In Vitro:

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
    Article Snippet: Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.. A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.. A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.

    Incubation:

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
    Article Snippet: Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.. A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.. A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.

    Agarose Gel Electrophoresis:

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
    Article Snippet: Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.Western Blot Analysis—A polyclonal Ab against the N-terminal peptide of both DFF35 and DFF45 (EVTGDAGVPESGEIRTLPKC) was from Upstate Biotechnology.. A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.. A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.A monoclonal Ab against epitope Flag (M5) was purchased from Sigma.



    Similar Products

    93
    Santa Cruz Biotechnology polyclonal ab against intermediate peptide
    FIG. 2. Both RNA transcripts and proteins of DFF35/45 exist in vivo. A, DFF35 and DFF45 were amplified by human DFF35 (lanes 1 and 3) and DFF45 (lanes 2 and 4) out-encoding region primer sets in human fetal liver cDNA (lanes 1 and 2) or Jurkat cell line (lanes 3 and 4) using PCR. B, expression of DFF45 and DFF35 in Jurkat cells was immunoblotted by <t>polyclonal</t> Ab specific for N-terminal (lane 1), inter- mediate (lane 2), or C-terminal (lane 3), respectively. C, lysate of 293T cells transfected with DFF45 (lane1), DFF35 (lane 2), or an irrelevant protein p53 (lane 3) was immunoblotted by anti-Flag (M5) Ab (top panel), or anti DFF45/35 (bottom panel). Arrows indicate the trans- fected and endogenous DFF45 and DFF35.
    Polyclonal Ab Against Intermediate Peptide, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+ab+against+intermediate+peptide/Intermediate/pm10409614-59-1-25
    Average 93 stars, based on 1 article reviews
    polyclonal ab against intermediate peptide - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology polyclonal ab against intermediate peptide of both dff35 and dff45
    FIG. 2. Both RNA transcripts and proteins of DFF35/45 exist in vivo. A, DFF35 and DFF45 were amplified by human DFF35 (lanes 1 and 3) and DFF45 (lanes 2 and 4) out-encoding region primer sets in human fetal liver cDNA (lanes 1 and 2) or Jurkat cell line (lanes 3 and 4) using PCR. B, expression of DFF45 and DFF35 in Jurkat cells was immunoblotted by <t>polyclonal</t> Ab specific for N-terminal (lane 1), inter- mediate (lane 2), or C-terminal (lane 3), respectively. C, lysate of 293T cells transfected with DFF45 (lane1), DFF35 (lane 2), or an irrelevant protein p53 (lane 3) was immunoblotted by anti-Flag (M5) Ab (top panel), or anti DFF45/35 (bottom panel). Arrows indicate the trans- fected and endogenous DFF45 and DFF35.
    Polyclonal Ab Against Intermediate Peptide Of Both Dff35 And Dff45, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+ab+against+intermediate+peptide/antibody+to+goat+anti+human+dff45++c+19+/pm10409614-59-10-25
    Average 90 stars, based on 1 article reviews
    polyclonal ab against intermediate peptide of both dff35 and dff45 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    FIG. 2. Both RNA transcripts and proteins of DFF35/45 exist in vivo. A, DFF35 and DFF45 were amplified by human DFF35 (lanes 1 and 3) and DFF45 (lanes 2 and 4) out-encoding region primer sets in human fetal liver cDNA (lanes 1 and 2) or Jurkat cell line (lanes 3 and 4) using PCR. B, expression of DFF45 and DFF35 in Jurkat cells was immunoblotted by polyclonal Ab specific for N-terminal (lane 1), inter- mediate (lane 2), or C-terminal (lane 3), respectively. C, lysate of 293T cells transfected with DFF45 (lane1), DFF35 (lane 2), or an irrelevant protein p53 (lane 3) was immunoblotted by anti-Flag (M5) Ab (top panel), or anti DFF45/35 (bottom panel). Arrows indicate the trans- fected and endogenous DFF45 and DFF35.

    Journal: The Journal of biological chemistry

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.

    doi: 10.1074/jbc.274.30.20759

    Figure Lengend Snippet: FIG. 2. Both RNA transcripts and proteins of DFF35/45 exist in vivo. A, DFF35 and DFF45 were amplified by human DFF35 (lanes 1 and 3) and DFF45 (lanes 2 and 4) out-encoding region primer sets in human fetal liver cDNA (lanes 1 and 2) or Jurkat cell line (lanes 3 and 4) using PCR. B, expression of DFF45 and DFF35 in Jurkat cells was immunoblotted by polyclonal Ab specific for N-terminal (lane 1), inter- mediate (lane 2), or C-terminal (lane 3), respectively. C, lysate of 293T cells transfected with DFF45 (lane1), DFF35 (lane 2), or an irrelevant protein p53 (lane 3) was immunoblotted by anti-Flag (M5) Ab (top panel), or anti DFF45/35 (bottom panel). Arrows indicate the trans- fected and endogenous DFF45 and DFF35.

    Article Snippet: A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.

    Techniques: In Vivo, Amplification, Expressing, Transfection

    FIG. 1. Comparison of amino acid sequences between DFF35 and DFF45 (A) or mouse ICAD-S (B). Two putative cleavage sites for caspase-3 are indicated by double underlines. Three peptides (N, I, and C) used to generate polyclonal antibodies are indicated by single under- lines. Identical amino acids between DFF35 and mouse ICAD-S are in bold face.

    Journal: The Journal of biological chemistry

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.

    doi: 10.1074/jbc.274.30.20759

    Figure Lengend Snippet: FIG. 1. Comparison of amino acid sequences between DFF35 and DFF45 (A) or mouse ICAD-S (B). Two putative cleavage sites for caspase-3 are indicated by double underlines. Three peptides (N, I, and C) used to generate polyclonal antibodies are indicated by single under- lines. Identical amino acids between DFF35 and mouse ICAD-S are in bold face.

    Article Snippet: A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.

    Techniques: Comparison

    FIG. 3. Inhibitory effect of DFF35 in vitro and in vivo. A, Jurkat cells were treated with 1 mg/ml Fas monoclonal Ab 7C11 for 2 h, and 100 ng of cytosolic fraction without (lane 1) or with GST (lanes 2 and 3), GST-DFF35 (lanes 4 and 5), or double mutated GST-DFF35 (lanes 6 and 7) was added to Jurkat nuclei and incubated at 37 °C for 2 h in the presence (lanes 3, 5, and 7) or absence (lanes 1, 2, 4, and 6) of caspase-3, respectively. Jurkat cells were treated with 1 mg/ml of staurosporine for the indicated time, cell lysates were blotted with polyclonal Ab reactive to N-terminal peptide of DFF45 and DFF35 (B), and genomic DNA were extracted and subjected to analysis by 2% agarose gel electrophoresis (C).

    Journal: The Journal of biological chemistry

    Article Title: Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.

    doi: 10.1074/jbc.274.30.20759

    Figure Lengend Snippet: FIG. 3. Inhibitory effect of DFF35 in vitro and in vivo. A, Jurkat cells were treated with 1 mg/ml Fas monoclonal Ab 7C11 for 2 h, and 100 ng of cytosolic fraction without (lane 1) or with GST (lanes 2 and 3), GST-DFF35 (lanes 4 and 5), or double mutated GST-DFF35 (lanes 6 and 7) was added to Jurkat nuclei and incubated at 37 °C for 2 h in the presence (lanes 3, 5, and 7) or absence (lanes 1, 2, 4, and 6) of caspase-3, respectively. Jurkat cells were treated with 1 mg/ml of staurosporine for the indicated time, cell lysates were blotted with polyclonal Ab reactive to N-terminal peptide of DFF45 and DFF35 (B), and genomic DNA were extracted and subjected to analysis by 2% agarose gel electrophoresis (C).

    Article Snippet: A polyclonal Ab against intermediate peptide of both DFF35 and DFF45 (KQEESKAAFGEEVDAVD) and a polyclonal Ab against C-terminal peptide of DFF45 only (KASPPGDLQNPKRARQDPT) were from Santa Cruz Biotechnology.

    Techniques: In Vitro, In Vivo, Incubation, Agarose Gel Electrophoresis